MERREM

This brand name is authorized in Mexico, New Zealand, United States

Active ingredients

The drug MERREM contains one active pharmaceutical ingredient (API):

1 Meropenem UNII FV9J3JU8B1 - MEROPENEM

Meropenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). Read about Meropenem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MERREM IV Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH02	Meropenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 426M95
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7342, 7343
Country: US	FDA, National Drug Code	Identifier(s): 0069-0313, 0069-0314